Pauline Funchain
Pauline Funchain
Geverifieerd e-mailadres voor ccf.org
Geciteerd door
Geciteerd door
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update
BJ Schneider, J Naidoo, BD Santomasso, C Lacchetti, S Adkins, ...
Journal of clinical oncology 39 (36), 4073-4126, 2021
Systemic therapy for melanoma: ASCO guideline
R Seth, H Messersmith, V Kaur, JM Kirkwood, R Kudchadkar, ...
Journal of Clinical Oncology 38 (33), 3947-3970, 2020
The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness
P Funchain, A Yeung, J Lee Stewart, R Lin, MM Slupska, JH Miller
Genetics 154 (3), 959-970, 2000
Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets
LJ Rush, A Raval, P Funchain, AJ Johnson, L Smith, DM Lucas, ...
Cancer research 64 (7), 2424-2433, 2004
Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq trial—ECOG-ACRIN EA6134
MB Atkins, SJ Lee, B Chmielowski, AA Tarhini, GI Cohen, TG Truong, ...
Journal of Clinical Oncology 41 (2), 186, 2023
Resumption of immune checkpoint inhibitor therapy after immune-mediated colitis
H Abu-Sbeih, FS Ali, AR Naqash, DH Owen, S Patel, GA Otterson, ...
Journal of clinical oncology 37 (30), 2738, 2019
In vitro and in vivo studies of MutS, MutL and MutH mutants: correlation of mismatch repair and DNA recombination
MS Junop, W Yang, P Funchain, W Clendenin, JH Miller
DNA repair 2 (4), 387-405, 2003
Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline
BD Santomasso, LJ Nastoupil, S Adkins, C Lacchetti, BJ Schneider, ...
Journal of clinical oncology 39 (35), 3978-3992, 2021
Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti–PD-1 therapies in metastatic melanoma
DB Johnson, J Bordeaux, JY Kim, C Vaupel, DL Rimm, TH Ho, ...
Clinical Cancer Research 24 (21), 5250-5260, 2018
Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas
H Wang, P Funchain, G Bebek, J Altemus, H Zhang, F Niazi, C Peterson, ...
Genome medicine 9, 1-10, 2017
Prospective clinical study of precision oncology in solid tumors
DPS Sohal, BI Rini, AA Khorana, R Dreicer, J Abraham, GW Procop, ...
Journal of the National Cancer Institute 108 (3), djv332, 2016
Escherichia coli Strains (ndk) Lacking Nucleoside Diphosphate Kinase Are Powerful Mutators for Base Substitutions and Frameshifts in Mismatch-Repair-Deficient …
JH Miller, P Funchain, W Clendenin, T Huang, A Nguyen, E Wolff, ...
Genetics 162 (1), 5-13, 2002
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
L Sun, P Funchain, JM Song, P Rayman, C Tannenbaum, J Ko, ...
Journal for immunotherapy of cancer 6, 1-7, 2018
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
YG Najjar, K Navrazhina, F Ding, R Bhatia, K Tsai, K Abbate, B Durden, ...
Journal for immunotherapy of cancer 8 (1), 2020
Increased incidence of venous thromboembolism with cancer immunotherapy
J Roopkumar, S Swaidani, AS Kim, B Thapa, L Gervaso, BP Hobbs, ...
Med 2 (4), 423-434. e3, 2021
Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor …
S Gandhi, MR Pandey, K Attwood, W Ji, AK Witkiewicz, ES Knudsen, ...
Clinical Cancer Research 27 (1), 87-95, 2021
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
TA Sussman, H Li, B Hobbs, P Funchain, KR McCrae, AA Khorana
Journal for immunotherapy of cancer 9 (1), 2021
Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance
PC Barata, VS Koshkin, P Funchain, D Sohal, A Pritchard, S Klek, ...
Annals of Oncology 28 (10), 2458-2463, 2017
Acute liver injury induced by weight-loss herbal supplements
GC Chen, VS Ramanathan, D Law, P Funchain, GC Chen, S French, ...
World Journal of Hepatology 2 (11), 410, 2010
Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome
R Kotecha, JA Miller, VA Venur, AM Mohammadi, ST Chao, JH Suh, ...
Journal of Neurosurgery 129 (1), 50-59, 2017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20